4th Annual MarketsandMarkets Next-Gen Bioprocessing Conference

20th - 21st October 2022 | Boston, USA
CONFERENCE SPEAKERS
Advisors
Tuhin Bhowmick
Tuhin Bhowmick
Founder & CEO,
Pandorum Int.



David Gemmell
David Gemmell
MSAT Biomanufacturing Engineer,
Merck



Speakers
Tuhin Bhowmick
Tuhin Bhowmick
Founder & CEO,
Pandorum Int.



David Gemmell
David Gemmell
MSAT Biomanufacturing Engineer,
Merck



Prasun Mishra
Prasun Mishra
Chief Executive Officer,
Precision Biopharma


Dr. Mishra (Ex-Genentech, Ex-NCI, Ex-NIH) is the founding president and CEO of the American Association for Precision Medicine (AAPM) and chair of ACT –AAPM’s Coronavirus Taskforce. He is leading research efforts focused on preventing & curing chronic diseases; not only treating the sick but also providing knowledge/tools to individuals to live longer, healthier lives. He is also the founder and CEO of Agility Pharmaceuticals, a pharmaceutical company committed to revolutionizing drug discovery & development through technology, big data, robotics, and artificial intelligence. He is a serial entrepreneur who founded his first company after graduating high school, and his second company during his Ph.D. Since then, he has accumulated a wealth of experience by building, investing, and advising numerous other companies. He is an investor, co-founder/ board member of a few corporations, focused on accelerating drug discovery/ development, data analytics, robotics, mental health, and digital health. He is also the founder of AAPM Angels and Investors (AAi), an investment group focused on investing in drug discovery, diagnostics, precision medicine, technology & healthcare companies. He is also the founding investor and advisor to Barcelona Ventures and serves as an advisor to a $100M private equity fund.


David Wood
David Wood
Professor,
The Ohio State University



Ehsan Mahdinia
Ehsan Mahdinia
Assistant Professor,
CBET-ACPHS



Jared Auclair
Jared Auclair
Associate Dean of Professional Program and Graduate Affairs,
Northeastern University



Laurens Vergauwen
Laurens Vergauwen
EMEA Process Development Scientist,
Merck



Erik Liu
Erik Liu
Process Development Scientist , Drug Substance Technologies,
Amgen



Joseph M. Roig
Joseph M. Roig
Associate Technical Director, Apheresis | Global MSAT Cell Therapy Development and Operations,
Bristol Myers Squibb



Carla Kreissig
Carla Kreissig
CEO and Medical Director,
Cellex Cell Professionals GmbH



Rachel Legmann
Rachel Legmann
Senior Director of Technology, Gene Therapy,
Repligen